Erez Eitan
Principal investigator, leads NEURODEX INC.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$5.3MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $5.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 14, 2025 | NIH | SBIR Phase II Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $518K | NEURODEX INC |
| Aug 19, 2024 | NIH | SBIR Phase II Blood-based Biomarker for Characterizing Progression and Therapeutic Response in Amyotrophic Lateral Sclerosis | $2.1M | NEURODEX INC |
| Aug 14, 2024 | NIH | SBIR Phase II Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $942K | NEURODEX INC |
| Sep 13, 2023 | NIH | SBIR Phase II Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $1.0M | NEURODEX INC |
| Sep 21, 2022 | NIH | SBIR Phase II Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | $450K | NEURODEX INC |
| Sep 1, 2019 | NIH | SBIR Phase I Presymptomatic Diagnostic Tools for Alzheimers Disease by Blood Neuron Derived Exosome Analysis | $212K | NEURODEX INC |
1 patents as inventor
- US NEURODEX INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#261
Awards as PI#349
Patents#505
Companies
- NEURODEX INCLeads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.